http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35170404

Outgoing Links

Predicate Object
contentType Journal Article|Multicenter Study
endingPage 1755
issn 2542-5641
0366-6999
issueIdentifier 14
pageRange 1753-1755
publicationName Chinese Medical Journal
startingPage 1753
bibliographicCitation Qu F, Wu D, Liu Y, Gao W, Wang S, Wang S, Jin F, Chen B, Huang J, Sun S, Fan Z; Chinese Society of Breast Surgery. Clinical evaluation of the first domestically produced generic isosulfan blue injection in sentinel lymph node biopsy for early breast cancer in China: a multicenter, single-arm, open validation trial (CSBrS-024). Chin Med J (Engl). 2022 Jul 20;135(14):1753–5. PMID: 35970595; PMCID: PMC9509065.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ec178f1dc4857573a90701155c4f59fe
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f0e4c64ed822ff61d05eec1608c87ae8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e864a442f9395bde4dd83bc818db0750
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_32e776d31988d16548b168d3fcaac6b5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3ae3db9c8577795fb80bd787c8c770b9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9ae6eeeb05873084acf84f1bc7e1fc66
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bb530bad5ad88764ee0c10914aa739ce
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a332c5b6fcddac4fc49ce98165e56c44
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6237cd374375e934b533d153c4bd6e49
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ee782b70a0d45ca3cbe6691153be9285
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bf5cc40245490ebbb4501d2bce9d7320
date 2022-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/35970595
https://pubmed.ncbi.nlm.nih.gov/PMC9509065
https://doi.org/10.1097/cm9.0000000000002309
isPartOf https://portal.issn.org/resource/ISSN/2542-5641
https://portal.issn.org/resource/ISSN/0366-6999
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2927
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Clinical evaluation of the first domestically produced generic isosulfan blue injection in sentinel lymph node biopsy for early breast cancer in China: a multicenter, single-arm, open validation trial (CSBrS-024)
discusses http://id.nlm.nih.gov/mesh/M0019268
http://id.nlm.nih.gov/mesh/M0084883
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D021701
http://id.nlm.nih.gov/mesh/D001943Q000473
hasSubjectTerm http://id.nlm.nih.gov/mesh/D008198Q000473
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D008207
http://id.nlm.nih.gov/mesh/D012394
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID50108
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102

Total number of triples: 42.